Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 277 - Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
Patents for C07D 277 - Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings (33,621)
10/2003
10/28/2003US6639081 Reacting an aminonitrile and a cysteine ester; oxidizing without isolating
10/28/2003US6638979 Imidamide derivatives
10/28/2003US6638967 Pyrrole, furan, thiofuran and phenyl derivatives; inhibition of histamine H3 receptor activity; for example, 1-((4-(4-Pyrrolidin-1-ylmethyl-phenyl)-thien-2-yl)methyl)-pyrrolidine
10/23/2003WO2003087084A1 3-aminophenol derivatives and dyes that contain these compounds while serving to dye keratin fibers
10/23/2003WO2003087068A1 Process for preparing heteroaryl and unsaturated heterocycloalkylmagnesium reagents and uses
10/23/2003WO2003087062A2 4-(heterocyclyl)-benzenesulfoximine compounds for the treatment of inflammation
10/23/2003WO2003087057A1 Benzamide derivatives useful as histone deacetylase inhibitors
10/23/2003WO2003087037A1 Substituted aryl amides
10/23/2003WO2003086341A2 Aminophenylbenzothiazole compounds
10/23/2003US20030199701 Treating under hydrolyzing conditions a hydantoin compound to form an alpha-amino acid derivative
10/23/2003US20030199580 Condensation of amine derivative with carboxylic acid derivatives to afford intermediate compound, followed by cyclization of intermediate compound in presence of acid; hyopoglycemic action
10/23/2003US20030199562 Substituted benzoxazoles as estrogenic agents
10/23/2003US20030199560 Bisaryl compound and medicament for cancer treatment comprising the same
10/23/2003US20030199521 Compounds, methods and compositions useful for the treatment of bovine viral diarrhea virus (BVDV) infection and hepatitis C virus (HCV) infection
10/23/2003US20030199503 A thiazole-5-carboxylic acid derivatives as viricides, for treating Hepatitis
10/23/2003US20030199501 A sulfonylamino-tetrahydro(1,3)thiazolo(5,4-c)pyridinyl or benzothiazole derivatives, for treating diabetes, syndrome X, obesity, glaucoma, hyperlipidemia, hyperglycemia, hyperinsulinemia, osteoporosis, tuberculosis, dementia
10/23/2003US20030199482 Anticholesterol agents; a drug mixture for treating hypercholesterolemia comprising an apical sodium co-dependent bile acid transport inhibitor, enzyme inhibitors of a cyclooxygenase-2
10/23/2003US20030199479 Oxa(thia)zolidine derivative and anti-inflammatory drug
10/23/2003CA2482207A1 Process for preparing heteroaryl and unsaturated heterocycloalkylmagnesium reagents and uses
10/23/2003CA2480856A1 Substituted aryl amides
10/22/2003EP1354880A1 Halogen compounds having thrombopoietin receptor agonism
10/22/2003EP1354879A1 Dihydronaphthalene derivative compounds and drugs containing these compounds as the active ingredient
10/22/2003EP1353912A1 2-arylimino-2,3-dihydrothiazole derivatives, methods for preparing them and therapeutic use thereof
10/22/2003EP1353911A1 Antiviral agents
10/22/2003EP1353898A2 Compounds to treat alzheimer's disease
10/22/2003EP1353676A1 Method for treating fibrotic diseases or other indications
10/22/2003EP1353669A1 Method for treating glaucoma ib
10/22/2003EP1353662A2 Methods for the treatment of diseases using malonyl-coa decarbox ylase inhibitors
10/22/2003EP1255538B1 Use of 2-methyl-thiazolidin-2,4-dicarboxylic acid (2-mtdc) and/or physiologically compatible salts for the manufacture of a medicament for treating and/or preventing cancers
10/22/2003CN1450993A Fungicidal heterocyclic aromatic amides and their compositions methods of use and preparation
10/22/2003CN1450989A 7-substituted tetracycline compounds
10/22/2003CN1125048C Method for producing isoureas
10/22/2003CN1125045C Process for producing intermecliates used in process for producing-2-iminothiazoline derivatives
10/22/2003CN1125044C Novel prostaglandin synthase inhibitors
10/21/2003CA2288003C Pharmaceutical compositions of tizoxanide and nitazoxanide
10/21/2003CA2240136C Phenyl-and aminophenyl-alkylsulfonamide and urea derivatives
10/21/2003CA2213737C 2-arylbenzazole compounds
10/21/2003CA2003480C Fungicides
10/16/2003WO2003084940A1 Thiazolidine-4-carbonitriles and analogues and their use as dipeptidyl-peptidas inhibitors
10/16/2003WO2003084927A1 Haloalkenes, process for production thereof, and pest controllers containing the same
10/16/2003WO2003084537A1 Therapeutic agent for food competence disorder in stomach
10/16/2003WO2002072009A3 Heterocyclic derivatives for the treatment of cancer and other proliferative diseases
10/16/2003WO2001066534A3 Cyclic and bicyclic diamino histamine-3 receptor antagonists
10/16/2003US20030195362 For therapy of retroviral infection and in particular an HIV infection
10/16/2003US20030195354 For use as fungicide
10/16/2003US20030195238 Enzyme inhibitors
10/16/2003US20030195231 Heterocyclic sulfur compounds and/or prodrugs administered for prophylaxis of thrombocytopenia, anemia or blood disorders
10/16/2003US20030195224 An immunomodulators, antitumor agents and induce cytokine biosynthesis, treating viral diseases
10/16/2003US20030195219 Hybrid 2-aminotetralin and aryl-substituted piperazine compounds and their use in altering cns activity
10/16/2003US20030195213 A methylene-4-oxo-2-thionothiazolidin derivatives viricides for treating infections caused by Flavivirous
10/16/2003US20030195202 Inhibitors of IMPDH enzyme
10/16/2003US20030195201 Vanilloid receptor ligands and their use in treatments
10/16/2003CA2481995A1 Thiazolidine-4-carbonitriles and analogues and their use as dipeptidyl-peptidas inhibitors
10/16/2003CA2481916A1 A therapeutic agent for impaired gastric accommodation
10/15/2003EP1352900A1 Process to prepare taxol
10/15/2003EP1352899A1 Process to prepare taxol
10/15/2003EP1352650A1 Inhibitors against the production and release of inflammatory cytokines
10/15/2003EP1352032A1 Dispers-reactive dyes containing acetoxymethylsulfone or vinylsulfone and their process
10/15/2003EP1351946A2 Materials and methods to potentiate cancer treatment
10/15/2003EP1351945A1 Novel 1,4-diamino-2-(thiazol-2-yl)benzene derivatives and dyes containing said compounds
10/15/2003EP1206457B1 Biaryl-oxa(thia)zole derivatives and their use as ppars modulators
10/15/2003EP0916651B1 Phenylalkylcarboxylic acid derivatives
10/15/2003EP0861246B1 Prolyl endopeptidase inhibitors, their preparation and their pharmaceutical use
10/15/2003EP0831769B1 Novel uses for thyroid hormones or thyroid hormone-like compounds
10/15/2003CN1449380A Phenoxybenzylamine derivatives as selective serotonin re-uptake inhibitors
10/15/2003CN1448392A Methionyl aminopeptidase inhibitor
10/14/2003US6632962 Caspase inhibitors and uses thereof
10/14/2003US6632947 Process for the preparation of substituted thiazolidinedione
10/14/2003US6632831 Branched chain amino acid-dependent aminotransferase inhibitors and their use in the treatment of neurodegenerative diseases
10/14/2003US6632830 ACE-2 inhibiting compounds and methods of use thereof
10/14/2003US6632815 Show selectivity for factor Xa versus other proteases of coagulation or the fibrinolytic cascades
10/14/2003US6632810 Cyclic diamine compound with condensed-ring groups
10/09/2003WO2003082865A1 Medicinal antitumor composition
10/09/2003WO2003082840A1 κ-OPIOID RECEPTOR AGONIST COMPRISING 2-PHENYLBENZOTHIAZOLINE DERIVATIVE
10/09/2003WO2003082839A1 (4,2-disubstituted-thiazol-5-yl)amine compounds as pde7 inhibitors
10/09/2003WO2003082838A1 New methionine aminopeptidase inhibitor
10/09/2003WO2003082829A1 New aryl imidazoles and related compounds as c5a receptor modulators
10/09/2003WO2003082280A1 Glucocorticoid mimetics, methods of making them, pharmaceutical compositions, and uses thereof
10/09/2003WO2003082278A1 Thiazolidine carboxamide derivatives as modulators of the prostaglandin f receptor
10/09/2003WO2003082277A1 Thiazol-2-yl-imine compounds as pde-7 inhibitors
10/09/2003WO2003082268A2 Hemiasterlin derivatives and uses thereof in the treatment of cancer
10/09/2003WO2002030357A9 Compounds and methods for modulating ccr4 function
10/09/2003WO2001079189A3 'amides of r-2-(aminoaryl)-propionic acids for use in theprevention of leucocyte activation'
10/09/2003US20030191321 Chemical intermediates 2-hydroxy-5-hydroxymethylthiazole, chlorination to form 2-chloro-5-chloromethylthiazole, which is a known compound for the preparation of insecticides
10/09/2003US20030191320 Process for the preparation of bis-benzazolyl compounds
10/09/2003US20030191319 Alpha-and beta-amino acid hydroxyethylamino sulfonamides useful as retroviral protease inhibitors
10/09/2003US20030191279 Of given formula; treatment of hyperproliferative disorders, pancreatitis, kidney disease, vasculogenesis or angiogenesis
10/09/2003US20030191167 Autoimmune disease, antiarthritic agents, antiallergens, anticancer agents
10/09/2003US20030191166 Sulfonylalkanoylamino hydroxyethylamino sulfonamide retroviral protease inhibitors
10/09/2003US20030191164 Propane-1,3-dione derivatives
10/09/2003US20030191156 Antidiabetic agents; dietetics
10/09/2003US20030191139 Anticoagulant for mammals
10/09/2003US20030191118 Inhibitors of alpha4 mediated cell adhesion
10/09/2003US20030191110 Anticholesterol agents; cardiovascular disorders
10/09/2003US20030191089 Anticancer agents
10/09/2003CA2480888A1 New aryl imidazoles and related compounds as c5a receptor modulators
10/09/2003CA2480679A1 (4,2-disubstituted-thiazol-5-yl)amine compounds as pde7 inhibitors
10/09/2003CA2480568A1 Thiazol-2-yl-imine compounds as pde-7 inhibitors
10/09/2003CA2479764A1 Hemiasterlin derivatives and uses thereof
10/09/2003CA2477265A1 Thiazolidine carboxamide derivatives as modulators of the prostaglandin f receptor
1 ... 161 162 163 164 165 166 167 168 169 170 171 172 173 174 175 176 177 178 179 180 181 ... 337